Table 4.

Clinical details

	Months of follow-up after ITA initiation
	0 (n=8)	1 (n=8)	3 (n=8)	6 (n=8)	9 (n=8)	12 (n=8)	18 (n=4)	24 (n=3)
VA mean, logMAR	0.53	0.51	0.47	0.50	0.52	0.59	0.63	0.54
VA change by ≥2 lines
Improved, n (%)	NA	0	0	0	2 (25)	2 (25)	0	0
Stable, n (%)	NA	8 (100)	8 (100)	7 (88)	5 (62)	4 (50)	3 (75)	2 (67)
Worse, n (%)	NA	0	0	1 (12)	1 (12)	2 (25)	1 (25)	1 (33)
CFT, µm	417	339	377	356	339	357	548	609

CFT, central foveal thickness; ITA, intravitreal triamcinolone acetonide; VA, visual acuity.